Patent Litigation Europe Summit (formerly Pharma & Biotech Patent Litigation) returns to Amsterdam with IPKat readers' discount
 |
| If you're looking for gifts for your litigator Kat ... |
Now in its 5th edition, the Patent Litigation Europe Summit has expanded and will bring together over 800 senior IP leaders (with 45% in-house counsel) for three days of case law updates, judicial insight, and strategic networking.
For the first time, the summit offers two concurrent tracks to reflect the evolving nature of patent disputes across industries:
Pharma & Biotech Patent Litigation
Covering the full life sciences IP spectrum, from preliminary injunctions, SPCs, and second medical use claims to navigating Bolar exemptions and exclusivity challenges in the UPC era.
Speakers include:
- Ewan Nettleton, Principal IP Counsel- Oncology Litigation, Novartis
- Shohta Ueno, Associate General Counsel- Dispute Resolution, Regeneron
- Philippe Bessiere, Global Head of Patents, Pierre Fabre
- James Robertson, Head of Global IP, bioMérieux
- Raquel Frisardi, Associate General Counsel, Novo Nordisk
- Elisabeth Haselhorst, IP Litigation, Bayer
- Andreas Robinson, Senior Counsel- IP & Litigation Law, Amgen
Tech & Innovation Patent Litigation
Focusing on the fast-moving world of technology, connectivity, and innovation, from FRAND and SEP disputes to trade secrets, AI, and the role of national courts vs the UPC in shaping global enforcement.
Speakers include:
- Le Chen, Senior Director – IP Policy & Dispute Resolution, Xiaomi
- Julia Dias, Senior IP Policy Counsel, Huawei
- David Goodfellow, Chief IP Counsel, APTIV
- Ief Daems, Assistant General Counsel, CISCO
- Bas Van Buul, Director of IP, Inalfa Roof Systems
- Mitsuaki Masumura, Head of Licensing AP & EMEA, IBM
The members of the judicial speaking faculty include:
- Colin Birss LJ, Honourable Judge, England and Wales Court of Appeal
- Peter Blok, Honourable Judge, UPC Court of Appeal
- Emmanuel Gougé, Honourable Judge, UPC Court of Appeal
- Ronny Thomas, Honourable Judge, UPC Local Division
- Margot Kokke, Honourable Judge, UPC Local Division
Across both tracks, attendees will hear directly from judges, regulators, in-house counsel, and leading litigators, making this a great opportunity to understand the perspectives shaping the future of patent law in Europe.
As usual, IPKat readers are entitled to a 10% discount in the registration fee, using VIP code IPKAT10 at checkout. To register, click here.
Patent Litigation Europe Summit (formerly Pharma & Biotech Patent Litigation) returns to Amsterdam with IPKat readers' discount
Reviewed by Eleonora Rosati
on
Tuesday, September 30, 2025
Rating:
Reviewed by Eleonora Rosati
on
Tuesday, September 30, 2025
Rating:
Follow the IPKat on LinkedIn 
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html